Correlation Between Milestone Pharmaceuticals and LENZ Therapeutics
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and LENZ Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and LENZ Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and LENZ Therapeutics, you can compare the effects of market volatilities on Milestone Pharmaceuticals and LENZ Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of LENZ Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and LENZ Therapeutics.
Diversification Opportunities for Milestone Pharmaceuticals and LENZ Therapeutics
0.84 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Milestone and LENZ is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and LENZ Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LENZ Therapeutics and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with LENZ Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LENZ Therapeutics has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and LENZ Therapeutics go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and LENZ Therapeutics
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to generate 1.03 times less return on investment than LENZ Therapeutics. In addition to that, Milestone Pharmaceuticals is 1.06 times more volatile than LENZ Therapeutics. It trades about 0.3 of its total potential returns per unit of risk. LENZ Therapeutics is currently generating about 0.33 per unit of volatility. If you would invest 2,821 in LENZ Therapeutics on August 30, 2024 and sell it today you would earn a total of 909.00 from holding LENZ Therapeutics or generate 32.22% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. LENZ Therapeutics
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| LENZ Therapeutics |
Milestone Pharmaceuticals and LENZ Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and LENZ Therapeutics
The main advantage of trading using opposite Milestone Pharmaceuticals and LENZ Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, LENZ Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LENZ Therapeutics will offset losses from the drop in LENZ Therapeutics' long position.The idea behind Milestone Pharmaceuticals and LENZ Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| LENZ Therapeutics vs. Ikena Oncology | LENZ Therapeutics vs. Eliem Therapeutics | LENZ Therapeutics vs. HCW Biologics | LENZ Therapeutics vs. RenovoRx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |